Key Takeaways The Biden administration proposed a new policy Tuesday that would allow Medicare and Medicaid to cover medications prescribed to treat obesity, such as Ozempic and Wegovy, in 2026.Under current rules,

Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare and Medicaid under a new rule the Biden administration proposed Tuesday morning.